CVS Health Corporation (CVS) Ownership
CVS ownership summary
as of October 18, 2026- Institutions
- 91.0% of shares outstanding
- Insiders
- 0.06% of shares outstanding
- Shares outstanding
- 1.28B
- Float
- 1.28B shares available to trade
- Short interest
- 1.30% 16.5M shares short
- Days to cover
- 2.12 short interest down 9.1% vs prior month
- Institutions 91.04%
- Insiders 0.06%
- Other investors 8.90%
CVS top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 9.63% | 123.2M | $11.38B | −2.7M (−2.1%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 6.51% | 83.3M | $7.70B | +665,293 (+0.8%) | June 30, 2026 |
| 3 | Capital World Investors | 5.86% | 75.0M | $6.92B | −2.3M (−3.0%) | June 30, 2026 |
| 4 | State Street Corp | 4.71% | 60.3M | $5.57B | +961,227 (+1.6%) | June 30, 2026 |
| 5 | Dodge & Cox | 3.91% | 50.0M | $4.62B | −1.8M (−3.4%) | June 30, 2026 |
| 6 | Wellington Management Company LLP | 2.64% | 33.8M | $3.12B | +11.2M (+49.8%) | June 30, 2026 |
| 7 | Geode Capital Management, LLC | 2.34% | 29.9M | $2.76B | +440,611 (+1.5%) | June 30, 2026 |
| 8 | FMR Inc | 2.26% | 28.9M | $2.67B | −2.3M (−7.3%) | June 30, 2026 |
| 9 | Vanguard Portfolio Management, LLC | 2.08% | 26.6M | $2.46B | +639,911 (+2.5%) | June 30, 2026 |
| 10 | Capital Research Global Investors | 1.90% | 24.3M | $2.25B | +4.3M (+21.6%) | June 30, 2026 |
| 11 | T. Rowe Price Associates, Inc. | 1.89% | 24.2M | $2.24B | +420,739 (+1.8%) | June 30, 2026 |
| 12 | Bank of America Corp | 1.81% | 23.2M | $2.14B | +13.8M (+148.0%) | June 30, 2026 |
| 13 | JPMorgan Chase & Co | 1.73% | 22.1M | $2.04B | −7.4M (−25.1%) | June 30, 2026 |
| 14 | Amvescap Plc. | 1.61% | 20.6M | $1.90B | −4.5M (−18.1%) | June 30, 2026 |
| 15 | Morgan Stanley - Brokerage Accounts | 1.45% | 18.6M | $1.72B | +780,906 (+4.4%) | June 30, 2026 |
| 16 | NORGES BANK | 1.41% | 18.0M | $1.67B | −3.0M (−14.1%) | June 30, 2026 |
| 17 | Capital Research & Mgmt Co - Division 3 | 1.20% | 15.4M | $1.42B | −4,622 (−0.0%) | June 30, 2026 |
| 18 | The Goldman Sachs Group Inc | 1.05% | 13.4M | $1.24B | +772,006 (+6.1%) | June 30, 2026 |
| 19 | Charles Schwab Investment Management Inc | 1.04% | 13.3M | $1.22B | −415,611 (−3.0%) | June 30, 2026 |
| 20 | Davis Selected Advisers | 0.93% | 11.9M | $1.10B | −373,750 (−3.1%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 34.1M shares and 10 cut 24.7M.
CVS top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.17% | 40.5M | $3.74B | −78,512 (−0.2%) | August 31, 2026 |
| 2 | Vanguard 500 Index Investor | 2.63% | 33.6M | $3.10B | −308,577 (−0.9%) | September 30, 2026 |
| 3 | Dodge & Cox Stock I | 2.48% | 31.7M | $2.93B | −2.2M (−6.4%) | June 30, 2026 |
| 4 | American Funds Washington Mutual A | 2.47% | 31.6M | $2.92B | −100,000 (−0.3%) | September 30, 2026 |
| 5 | American Funds Income Fd of Amer A | 1.85% | 23.7M | $2.19B | — | September 30, 2026 |
| 6 | American Funds American Balanced A | 1.33% | 17.1M | $1.58B | −864,473 (−4.8%) | September 30, 2026 |
| 7 | iShares Core S&P 500 ETF | 1.33% | 17.0M | $1.57B | −27,417 (−0.2%) | September 30, 2026 |
| 8 | Fidelity 500 Index | 1.29% | 16.6M | $1.53B | +63,611 (+0.4%) | August 31, 2026 |
| 9 | State Street® SPDR® S&P 500® ETF | 1.23% | 15.7M | $1.45B | — | September 30, 2026 |
| 10 | Vanguard MStar Value Index Investor | 0.95% | 12.2M | $1.13B | −16,386 (−0.1%) | September 30, 2026 |
| 11 | Vanguard Health Care Inv | 0.76% | 9.7M | $899.7M | −15,233 (−0.2%) | June 30, 2026 |
| 12 | American Funds American Mutual A | 0.76% | 9.7M | $895.0M | −789,446 (−7.5%) | September 30, 2026 |
| 13 | State Street®HlthCrSelSectSPDR®ETF | 0.71% | 9.1M | $837.7M | +28,208 (+0.3%) | September 30, 2026 |
| 14 | American Funds Fundamental Invs A | 0.66% | 8.5M | $785.1M | — | September 30, 2026 |
| 15 | Vanguard Institutional Index I | 0.53% | 6.8M | $624.8M | −56,138 (−0.8%) | September 30, 2026 |
| 16 | Vanguard Equity-Income Inv | 0.49% | 6.2M | $576.9M | +421,469 (+7.2%) | June 30, 2026 |
| 17 | BlackRock Equity Dividend Instl | 0.48% | 6.1M | $562.8M | −1.2M (−16.2%) | July 31, 2026 |
| 18 | Vanguard Wellington Inv | 0.46% | 5.9M | $543.7M | +5.9M (0.0%) | June 30, 2026 |
| 19 | Vanguard High Dividend Yield ETF | 0.41% | 5.2M | $482.2M | +14,258 (+0.3%) | September 30, 2026 |
| 20 | Strategic Advisers Fidelity US TtlStk | 0.33% | 4.3M | $392.7M | −234,902 (−5.2%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CVS insider transactions
latest 16| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-24 | Ro Khanna | Sell | $74.17 | — | — |
| 2026-02-20 | Michael T. McCaul | Buy | $76.64 | — | — |
| 2026-01-29 | John Boozman | Buy | $74.33 | — | — |
| 2026-01-29 | Ro Khanna | Sell | $74.33 | — | — |
| 2026-01-13 | Michael T. McCaul | Sell | $80.63 | — | — |
| 2025-11-21 | Dwight Evans | Sell | $77.92 | — | — |
| 2025-10-31 | Lisa C. McClain | Sell | $78.13 | — | — |
| 2025-10-30 | Lisa C. McClain | Buy | $76.70 | — | — |
| 2025-10-30 | Lisa C. McClain | Sell | $76.70 | — | — |
| 2025-10-27 | Michael T. McCaul | Sell | $82.44 | — | — |
| 2025-09-23 | Val T. Hoyle | Sell | $76.44 | — | — |
| 2025-08-22 | Michael T. McCaul | Sell | $71.17 | — | — |
| 2025-08-20 | Anne A Finucane | Sell | $71.02 | 7,500 | $532,650 |
| 2025-08-04 | Ro Khanna | Buy | $61.45 | — | — |
| 2025-06-27 | Michael T. McCaul | Sell | $68.50 | — | — |
| 2025-06-05 | Guy P Sansone | Buy | $63.70 | 1,570 | $100,009 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CVS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CVS
Institutional investors own 91.0% of CVS Health's shares and insiders 0.06%. The largest holder is BlackRock Inc with 9.63% of the shares (123.2M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 10 reduced their stake in the latest filings. Short interest is 1.30% of the float, or 2.12 days of average trading volume. The share count rose 13.2% since 2014.
Related: CVS analyst forecast, CVS key metrics, CVS dividend history. See the CVS stock overview for the latest quote and news.
CVS ownership FAQ
Who owns the most CVS Health stock?
The largest shareholders of CVS Health are BlackRock Inc (9.63%), Vanguard Capital Management, LLC (6.51%), Capital World Investors (5.86%), State Street Corp (4.71%), Dodge & Cox (3.91%).
What percentage of CVS Health is owned by institutions?
Institutions hold 91.0% of CVS Health's shares outstanding; insiders hold 0.06%.
Which funds own CVS Health?
The largest fund holders of CVS Health are Vanguard MStar Total Stk Mkt Idx Invest (3.17%), Vanguard 500 Index Investor (2.63%), Dodge & Cox Stock I (2.48%), American Funds Washington Mutual A (2.47%), American Funds Income Fd of Amer A (1.85%).
What is CVS Health's short interest?
16.5M shares of CVS Health were sold short, 1.30% of the float; at the average daily volume it would take 2.12 days to cover.
Are insiders buying or selling CVS Health?
Of the latest 16 reported insider transactions in CVS Health (since June 5, 2025), 5 were purchases and 11 were sales.
How many shares of CVS Health are outstanding?
CVS Health has 1.28B shares outstanding, of which 1.28B are in the public float.